163 related articles for article (PubMed ID: 2581699)
21. Conduction failure and nerve conduction slowing in experimental allergic neuritis induced by P2-specific T-cell lines.
Heininger K; Stoll G; Linington C; Toyka KV; Wekerle H
Ann Neurol; 1986 Jan; 19(1):44-9. PubMed ID: 2418761
[TBL] [Abstract][Full Text] [Related]
22. Neurophysiological changes in demyelinating and axonal forms of acute experimental autoimmune neuritis in the Lewis rat.
Taylor JM; Pollard JD
Muscle Nerve; 2003 Sep; 28(3):344-52. PubMed ID: 12929195
[TBL] [Abstract][Full Text] [Related]
23. Adoptive transfer-experimental allergic neuritis in newborn Lewis rats results in inflammatory infiltrates, mast cell activation, and increased Ia expression with only minor nerve fiber degeneration.
Pilartz M; Jess T; Indefrei D; Schröder JM
Acta Neuropathol; 2002 Nov; 104(5):513-24. PubMed ID: 12410399
[TBL] [Abstract][Full Text] [Related]
24. A permanent rat T cell line that mediates experimental allergic neuritis in the Lewis rat in vivo.
Linington C; Izumo S; Suzuki M; Uyemura K; Meyermann R; Wekerle H
J Immunol; 1984 Oct; 133(4):1946-50. PubMed ID: 6206142
[TBL] [Abstract][Full Text] [Related]
25. Suppression of experimental allergic neuritis by an antibody to the intracellular adhesion molecule ICAM-1.
Archelos JJ; Mäurer M; Jung S; Toyka KV; Hartung HP
Brain; 1993 Oct; 116 ( Pt 5)():1043-58. PubMed ID: 7693297
[TBL] [Abstract][Full Text] [Related]
26. Experimental allergic neuritis. Humoral and cellular immune responses to the cyanogen bromide peptides of the P2 protein.
Milek DJ; Cunningham JM; Powers JM; Brostoff SW
J Neuroimmunol; 1983 Apr; 4(2):105-16. PubMed ID: 6187769
[TBL] [Abstract][Full Text] [Related]
27. Suppression of P2-T-cell line mediated experimental autoimmune neuritis by interleukin-2 receptor blockade.
Hartung HP; Schäfer B; Diamantstein T; Fierz W; Heininger K; Toyka KV
Ann N Y Acad Sci; 1988; 540():563-5. PubMed ID: 2462831
[No Abstract] [Full Text] [Related]
28. Changes in T-cell subsets in experimental allergic neuritis.
Yamashita T; Negishi T; Nomura K; Hosokawa T; Ohno R; Hamaguchi K
Ann N Y Acad Sci; 1988; 540():720-2. PubMed ID: 2462844
[No Abstract] [Full Text] [Related]
29. Ciclosporin A prevents P2 T cell line-mediated experimental autoimmune neuritis (AT-EAN) in rat.
Hartung HP; Schäfer B; Fierz W; Heininger K; Toyka KV
Neurosci Lett; 1987 Dec; 83(1-2):195-200. PubMed ID: 2450307
[TBL] [Abstract][Full Text] [Related]
30. Transforming growth factor beta expression in reactive spinal cord microglia and meningeal inflammatory cells during experimental allergic neuritis.
Kiefer R; Gold R; Gehrmann J; Lindholm D; Wekerle H; Kreutzberg GW
J Neurosci Res; 1993 Nov; 36(4):391-8. PubMed ID: 7505838
[TBL] [Abstract][Full Text] [Related]
31. The B cell repertoire in experimental allergic neuritis involves multiple myelin proteins and GM1.
Zhu J; Link H; Weerth S; Linington C; Mix E; Qiao J
J Neurol Sci; 1994 Sep; 125(2):132-7. PubMed ID: 7528788
[TBL] [Abstract][Full Text] [Related]
32. Suppression of actively induced and passively transferred experimental allergic neuritis by cyclosporin A.
Nakayasu H; Ota K; Tanaka H; Irie H; Takahashi K
J Neuroimmunol; 1990 Mar; 26(3):219-27. PubMed ID: 1689744
[TBL] [Abstract][Full Text] [Related]
33. Interactions between CD4+ T-cells and rat Schwann cells in vitro. 1. Antigen presentation by Lewis rat Schwann cells to P2-specific CD4+ T-cell lines.
Argall KG; Armati PJ; Pollard JD; Watson E; Bonner J
J Neuroimmunol; 1992 Sep; 40(1):1-18. PubMed ID: 1381378
[TBL] [Abstract][Full Text] [Related]
34. Antigalactocerebroside antibody increases demyelination in adoptive transfer experimental allergic neuritis.
Hahn AF; Feasby TE; Wilkie L; Lovgren D
Muscle Nerve; 1993 Nov; 16(11):1174-80. PubMed ID: 7692294
[TBL] [Abstract][Full Text] [Related]
35. P2 protein-induced experimental allergic neuritis. An ultrastructural study.
Saida K; Saida T; Pleasure DE; Nishitani H
J Neurol Sci; 1983 Dec; 62(1-3):77-93. PubMed ID: 6199467
[TBL] [Abstract][Full Text] [Related]
36. Neuritogenic activity of peripheral nerve myelin proteins in Lewis rats.
Suzuki M; Kitamura K; Uyemura K; Ogawa Y; Ishihara Y; Matsuyama H
Neurosci Lett; 1980 Oct; 19(3):353-8. PubMed ID: 6189030
[TBL] [Abstract][Full Text] [Related]
37. A complementary peptide vaccine that induces T cell anergy and prevents experimental allergic neuritis in Lewis rats.
Araga S; Kishimoto M; Doi S; Nakashima K
J Immunol; 1999 Jul; 163(1):476-82. PubMed ID: 10384151
[TBL] [Abstract][Full Text] [Related]
38. Antibodies to P2 and P1 myelin antigens in experimental allergic neuritis and allergic encephalomyelitis.
Zweiman B; Moskovitz AR; Rostami A; Lisak RP; Pleasure DE; Brown MJ
J Neuroimmunol; 1982 Jun; 2(3-4):331-6. PubMed ID: 6177713
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of experimental autoimmune neuritis by an antibody to the lymphocyte function-associated antigen-1.
Archelos JJ; Mäurer M; Jung S; Miyasaka M; Tamatani T; Toyka KV; Hartung HP
Lab Invest; 1994 May; 70(5):667-75. PubMed ID: 8196363
[TBL] [Abstract][Full Text] [Related]
40. The role of myelin P2 protein in the production of experimental allergic neuritis.
Rostami A; Brown MJ; Lisak RP; Sumner AJ; Zweiman B; Pleasure DE
Ann Neurol; 1984 Dec; 16(6):680-5. PubMed ID: 6084458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
